Journal Article

Cholesterol Content of Very-Low-Density Lipoproteins Is Associated with 1-Year Mortality in Acute Heart Failure Patients

Vidović, Luka, Degoricija, Vesna, Frank, Saša, Berghold, Andrea, Madl, Tobias, Pregartner, Gudrun, Dokoza Terešak, Sanda, Klobučar, Iva, Potočnjak, Ines, Habisch, Hansjörg

2022

Overview

Considering the relationship between the extent of metabolic derangement and the disease severity in heart failure, we hypothesized that the lipid content of very-low-density lipoprotein (VLDL) may have prognostic value for 1 year mortality in acute heart failure (AHF). Baseline serum levels of VLDL cholesterol (VLDL-C), VLDL triglycerides (VLDL-TG), VLDL phospholipids (VLDL-PL), and VLDL apolipoprotein B (VLDL-apoB) were measured using NMR spectroscopy. We calculated the ratios of the respective VLDL lipids and VLDL apoB (VLDL-C/VLDL-apoB, VLDL-TG/VLDL-apoB, and VLDL-PL/VLDL-apoB), as estimators of the cholesterol, triglyceride, and phospholipid content of VLDL particles and tested their association with mortality. Out of 315 AHF patients, 118 (37.5%) patients died within 1 year after hospitalization for AHF. Univariable Cox regression analyses revealed a significant inverse association of VLDL-C/VLDL-apoB (hazard ratio (HR) 0.43, 95% confidence interval (CI) 0.29–0.64, p < 0.001), VLDL-TG/VLDL-apoB (HR 0.79, 95% CI 0.71–0.88, p < 0.001), and VLDL-PL/VLDL-apoB (HR 0.37, 95% CI 0.25–0.56, p < 0.001) with 1 year mortality. Of the tested parameters, only VLDL-C/VLDL-apoB remained significant after adjustment for age and sex, as well as other clinical and laboratory parameters that showed a significant association with 1 year mortality in the univariable analyses. We conclude that cholesterol content of circulating VLDL (VLDL-C/VLDL-apoB) might be of prognostic value in AHF.

• Publisher: MDPI AG,MDPI
• Subject: acute heart failure / Apolipoprotein B / Apolipoproteins B / Biomarkers / Cholesterol / Cholesterol, LDL / Cholesterol, VLDL / Congestive heart failure / Coronary artery disease / Health aspects / Heart diseases / Heart Failure / Hemoglobin / Hospitalization / Humans / Laboratories / Lipids / Lipoproteins / Lipoproteins (very low density) / Lipoproteins, VLDL - chemistry / Lipoproteins, VLDL - metabolism / Liver / Magnetic resonance spectroscopy / Measurement / Mortality / NMR / NMR spectroscopy / Nuclear magnetic resonance / Patient outcomes / Patients / Phospholipids / Prognosis / prognostic biomarkers / Proteins / Pulmonary arteries / Ratios / risk / Serum levels / Spectrum analysis / Triglycerides / very-low-density lipoprotein